Skip to main content

Table 3 Comparison of the characteristics from unrealistic pessimistic RP patients and unrealistic optimistic RP patients

From: Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients

Characteristics Unrealistic pessimistic RP patients, N = 32 Unrealistic optimistic RP patients, N = 24 p
Socio-demographic
 Female sex1 31 (96.9) 24 (100) 1
 Years of age 59.5 (49.6–64.6) 57.1 (43.3–61.7) 0.329
 Years of formal education 9 (6–15.8) 9 (6–12) 0.590
 Medium-low SE level1 29 (90.6) 24 (100) 0.252
RA-related
 Serum positive RF1 24 (75) 24 (100) 0.008
 Serum positive ACCP1 25 (78.1) 24 (100) 0.016
 Years of disease duration 13.5 (8.7–18) 18.5 (7.4–25) 0.329
 Rheumatoid nodes1 15 (46.9) 13 (54.2) 0.787
 RAPID-3 4.1 (1.4–12.6) 15.3 (14.1–18.7) 0.002
 High disease activity category1 6 (18.8) 19 (79.2) ≤ 0.0001
Patient-reported outcomes
 Pain-VAS 8 (3.3–14) 27.5 (7.6–36) 0.007
 Overall disease-VAS 7.5 (2–15) 32.5 (7.5–45.8) 0.001
 HAQ score 0.25 (0–1.1) 2 (1.4–2.5) ≤ 0.0001
 SF-36 score 77.2 (55.4–87.3) 42.5 (22.6–67) ≤ 0.0001
 Mental component score (SF-36) 71.9 (56.5–87.8) 48.1 (32–67) 0.002
 Physical component score (SF-36) 74 (48.9–84.6) 39.7 (17.4–53.3) ≤ 0.0001
Comorbidity
 Presence of comorbidity1 19 (59.4) 19 (79.2) 0.153
 Surgical joint replacement1 9 (28.1) 13 (54.2) 0.059
Treatment
 DMARDs/patient 1 (1–2) 2 (1–2) 0.165
 Corticosteroids use1 11 (34.4) 18 (75) 0.003
 Intensive treatment1 10 (31.3) 18 (75) 0.003
Compliance with treatment
 Adherence1 18 (56.3) 11 (45.8) 0.590
 Persistence1 19 (59.4) 111 (45.8) 0.418
 Concordance1 15 (46.9) 10 (41.7) 0.789
Miscellaneous
 Health Literacy1 24 (75) 22 (91.7) 0.162
 Adequate RA knowledge1 (based on CQ) 25 (44.6) 170 (47.4) 0.774
 RA family history1 18 (56.3) 10 (41.7) 0.418
Significant RP1 32 (100) 0 ≤ 0.0001
Unfavorable medical criteria 5 (5–6) 7.5 (7–8) ≤ 0.0001
  1. Data are presented as the median and IQR unless otherwise indicated
  2. 1Number (%) of patients
  3. SE socioeconomic, RF rheumatoid factor, ACCP antibodies to cyclic citrullinated peptides, RAPID-3 Routine Assessment of Patients Index Score-3, VAS visual analogue scale, HAQ Health Assessment Questionnaire, SF-36 Short Form-36, DMARDs disease-modifying anti-rheumatic drugs, CQ Compliance Questionnaire, RA rheumatoid arthritis, RP risk perception